Of note, G-CSF administration correlates with an increased risk of grade ≥ 2 CRS, though its use in patients with grade 1 CRS does not appear to worsen the condition [63,64,65,66,67]. This evidence concerns the gene CSF3 and congenital rubella syndrome.